RBC transfusion requirements after allogeneic marrow transplantation: Impact of the before-transplant Hb level on transfusion and early survival

Transfusion

Volumn 43, Issue 3, 2003, Pages 373-382

  Xenocostas, Anargyros ^a   Yee, Angelina ^b   Wong, Cindy J ^b   Sutton, David M C ^b   Lipton, Jeffrey H ^b   Kiss, Thomas L ^b   Messner, Hans A ^b  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BLOOD GROUP ABO INCOMPATIBILITY; BLOOD TRANSFUSION; CHRONIC MYELOID LEUKEMIA; COHORT ANALYSIS; CORRELATION ANALYSIS; ERYTHROCYTE TRANSFUSION; FEMALE; GRAFT VERSUS HOST REACTION; HEMOGLOBIN DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; STATISTICAL ANALYSIS; STATISTICAL MODEL; STEM CELL; SURVIVAL RATE;

ADOLESCENT; ADULT; AGED; BLOOD GROUP INCOMPATIBILITY; BONE MARROW TRANSPLANTATION; ERYTHROCYTE TRANSFUSION; FEMALE; GRAFT VS HOST DISEASE; HEMOGLOBINS; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, MYELOID, CHRONIC; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SEX CHARACTERISTICS; TIME FACTORS; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0037339698     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2003.00339.x     Document Type: Article

References (26)

1. Warkentin PI. Transfusion of patients undergoing bone marrow transplantation. Hum Pathol 1983;14:261-6.
2. Osterwalder B, Gratwohl A, Reusser P, et al. Hematological support in patients undergoing allogeneic bone marrow transplantation. Cancer Res 1988;108:44-52.
3. Philstedt P, Paulin T, Sundberg B, et al. Blood transfusion in marrow graft recipients. Ann Hematol 1992;65:66-70.
4. Bensinger W, Petersen FB, Banaji M, et al. Engraftment and transfusion requirements after allogeneic marrow transplantation for patients with acute non-lymphocytic leukemia in first complete remission. Bone Marrow Transplant 1989;4:409-14.
5. Link H, Boogaerts MA, Fauser AA, et al. A controlled trial of recombinant human erythropoietin after bone marrow transplantation. Blood 1994;84:3327-35.
6. Klaesson S, Ringden O, Ljungman P, et al. Reduced blood transfusion requirements after allogeneic bone marrow transplantation: results of a randomized, double-blind study with high dose erythropoietin. Bone Marrow Transplant 1994;13:397-402.
7. Steegman JL, Lopez J, Otero MJ, et al. Erythropoietin treatment in allogeneic BMT accelerates erythroid reconstitution: results of a prospective controlled randomized trial: Bone Marrow Transplant 1992;10:541-6.
8. Biggs JC, Atkinson KA, Booker V, Concannon A. Prospective randomized double-blind trial of the in vivo use of recombinant human erythropoietin in bone marrow transplantation from HLA-identical sibling donors. Bone Marrow Transplant 1995;15:129-34.
9. Curtis JE, Messner HA. Bone marrow transplantation for leukemia and aplastic anemia: management of ABO incompatibility. Can Med Assoc J 1982;126:649-55.
10. Couban S, Simpson DR, Barnett MJ, et al. A randomized multicentre comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies. Blood 2002;100:1525-31.
11. Couban S, Dranitsaris G, Andreou P, et al. Clinical and economic analysis of allogeneic peripheral blood progenitor cell transplants: a Canadian perspective. Bone Marrow Transplant 1998;22:1199-205.
12. Storb R, Deeg HJ, Whitehead J, et al. Methotrexate and cyclosporine compared to cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. N Engl J Med 1986;314:729-35.
13. Cox DR. Regression models and life tables. J R Stat Soc 1972;B34:187-220.
14. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
15. Strorb R, Weiden PL. Transfusion problems associated with transplantation. Semin Hematol 1981;18:163-76.
16. Slichter SL. Principles of transfusion support before and after bone marrow transplantation. In: Forman SJ, Blume KG, Thomas ED, editors. Bone marrow transplantation. Boston: Blackwell Scientific; 1994:273-98.
17. Braine HG, Sensenbrenner LL, Wright SK, et al. Bone marrow transplantation with major ABO blood group incompatibility using erythrocyte depletion of marrow prior to infusion. Blood 1982;60:420-5.
18. Sniecinski IJ, Petz LD, Oien L, Blume KG. Immunohematologic problems arising from ABO incompatible bone marrow transplantation. Transplant Proc 1987;19:4609-11.
19. Jin NR, Hill R, Segal G, et al. Preparation of red-blood-cell depleted marrow for ABO-incompatible marrow transplantation by density-gradient separation using the IBM 2991 blood cell processor. Exp Hematol 1987;15:93-8.
20. Bensinger WI, Martin PJ, Storer B, et al. Transplantation of bone marrow as compared with peripheral blood cells from HLA-identical relatives in patients with hematologic cancers. N Engl J Med 2001;344:175-81.
21. Blaise D, Kuentz M, Fortanier C, et al. Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: a report from the Société Française de Greffe de Moelle. J Clin Oncol 2000;18:537-46.
22. Vigorito AC, Azevedo WM, Marques JFC, et al. A randomized, prospective comparison of allogeneic bone marrow and peripheral blood progenitor cell transplantation in the treatment of hematological malignancies. Bone Marrow Transplant 1998;22:1145-51.
23. Caro JJ, Salas M, Ward A, Goss G. Anemia as an independent prognostic factor for survival in patients with cancer. Cancer 2001;91:2214-21.
24. Mitus AJ, Antin JH, Rutherford CJ, et al. Use of recombinant erythropoietin in allogeneic bone marrow transplant donor/recipient pairs. Blood 1994;83:1952-7.
25. Henry D. Haematological toxicities associated with dose-intensive chemotherapy, the role for and use of recombinant growth factors. Ann Oncol 1997;8:S7-10.
26. Littlewood TJ, Bajetta E, Nortier JWR, et al. Effects of epoietin alpha on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial. J Clin Oncol 2001;19:2865-74.